Rituximab is not associated with increased risk of second...

  • Main
  • 2020 / 07
  • Rituximab is not associated with increased risk of second...

Rituximab is not associated with increased risk of second primary malignancies in Israeli patients with diffuse large B cell lymphoma treated with RCHOP regimen

Neeman, Yuval, Perry, Chava, Silverman, Barbara, Waintraub, Nizan, Avivi, Irit
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Leukemia & Lymphoma
DOI:
10.1080/10428194.2020.1779257
Date:
July, 2020
File:
PDF, 1.09 MB
2020
Conversion to is in progress
Conversion to is failed